World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
15449
World Ranking
13626
National Ranking
244

Overview

Liliane Michalik is affiliated with the University of Lausanne in Switzerland. Their research spans several fields, predominantly within Medicine and Biochemistry, Genetics, and Molecular Biology. The scientist has contributed to subfields including Molecular Biology, Oncology, Immunology, Gender Studies, and Rheumatology.

The academic work of Liliane Michalik encompasses a range of topics, including:

  • IL-33, ST2, and ILC Pathways
  • Immune Cell Function and Interaction
  • Eosinophilic Disorders and Syndromes
  • Redox biology and oxidative stress
  • Melanoma and MAPK Pathways
  • Cell Adhesion Molecules Research
  • Diversity and Career in Medicine

Liliane Michalik has published research articles in various reputable venues. Notable publication venues include:

  • Nature Communications
  • Scientific Reports
  • Cell
  • The FASEB Journal
  • bioRxiv (Cold Spring Harbor Laboratory)

Significant recent papers authored or co-authored by Liliane Michalik cover several aspects of molecular and cellular biology related to immune and cancer biology:

  • PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions, 2021, Nature Communications
  • Low expression of the PPARγ-regulated gene thioredoxin-interacting protein accompanies human melanoma progression and promotes experimental lung metastases, 2021, Scientific Reports
  • Closing the scissor-shaped curve: Strategies to promote gender equality in academia, 2024, Cell
  • Transcriptional and functional regulation of cell cycle and UV response by PPARβ in human skin epidermal cells, 2024, The FASEB Journal
  • Estrogen Receptors/E2F1/CDKN3 Axis Protects from UV-induced Skin Cancers in Females, 2025, bioRxiv (Cold Spring Harbor Laboratory)

The scientist frequently collaborates with other researchers. Regular co-authors include:

  • Carine Winkler
  • Stefanie Ginster
  • Stéphanie Claudinot
  • Paris Jafari
  • Giuseppe Ercolano

Best Publications

  • International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

    Liliane Michalik;Johan Auwerx;Joel P. Berger;V. Krishna Chatterjee

  • Transcriptional Regulation of Metabolism

    Béatrice Desvergne;Liliane Michalik;Walter Wahli

  • From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

    Jérôme N. Feige;Laurent Gelman;Liliane Michalik;Béatrice Desvergne

  • Peroxisome-proliferator-activated receptors and cancers: complex stories.

    Liliane Michalik;Béatrice Desvergne;Walter Wahli

  • PPARs at the crossroads of lipid signaling and inflammation

    Walter Wahli;Liliane Michalik

  • Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

    Pascal Escher;Olivier Braissant;Sharmila Basu-Modak;Liliane Michalik

  • Critical roles of PPARβ/δ in keratinocyte response to inflammation

    Nguan Soon Tan;Liliane Michalik;Noa Noy;Noa Noy;Rubina Yasmin

  • Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice

    Liliane Michalik;Béatrice Desvergne;Nguan Soon Tan;Sharmila Basu-Modak

  • Reciprocal Regulation of Brain and Muscle Arnt-Like Protein 1 and Peroxisome Proliferator-Activated Receptor α Defines a Novel Positive Feedback Loop in the Rodent Liver Circadian Clock

    Laurence Canaple;Juliette Rambaud;Ouria Dkhissi-Benyahya;Béatrice Rayet

  • Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

    Nicolas Di-Poı̈;Nguan Soon Tan;Liliane Michalik;Walter Wahli

  • PPARs: transcriptional effectors of fatty acids and their derivatives.

    A.K. Hihi;L. Michalik;W. Wahli

  • Be fit or be sick: peroxisome proliferator-activated receptors are down the road.

    Béatrice Desvergne;Liliane Michalik;Walter Wahli

  • A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.

    Jennifer Rieusset;Fethi Touri;Liliane Michalik;Pascal Escher

  • Direct G Protein Modulation of Cav2 Calcium Channels

    H. William Tedford;Gerald W. Zamponi

  • Involvement of PPAR nuclear receptors in tissue injury and wound repair

    Liliane Michalik;Walter Wahli

  • Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.

    Liliane Michalik;Walter Wahli

  • Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.

    Liliane Michalik;Walter Wahli

  • PPARs in diseases: control mechanisms of inflammation.

    Radina Kostadinova;Walter Wahli;Liliane Michalik

  • Peroxisome-Proliferator-Activated Receptor (PPAR)-γ Activation Stimulates Keratinocyte Differentiation

    Man Mao-Qiang;Ashley J. Fowler;Matthias Schmuth;Peggy Lau

  • Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes

    Anna Planavila;Ricardo Rodríguez-Calvo;Mireia Jové;Liliane Michalik

Frequent Co-Authors

Walter Wahli
Walter Wahli University of Lausanne
Béatrice Desvergne
Béatrice Desvergne University of Lausanne
Nguan Soon Tan
Nguan Soon Tan Nanyang Technological University
Manuel Vázquez-Carrera
Manuel Vázquez-Carrera University of Barcelona
Pierre Chambon
Pierre Chambon Institute of Genetics and Molecular and Cellular Biology
Daniel Metzger
Daniel Metzger Institute of Genetics and Molecular and Cellular Biology
Frans Schuit
Frans Schuit KU Leuven
Curzio Rüegg
Curzio Rüegg University of Fribourg
Mercy M. Davidson
Mercy M. Davidson Columbia University
Karl-Heinz Krause
Karl-Heinz Krause University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Liliane Michalik

Trending Scientists